In conclusion, we suggest that serum leptin can identify NAFLD without obesity as a confounding factor, whereas adiponectin combined with specific serum lipids might be advantageous for NAFL vs. NASH stratification. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.